However, adiponectin effects on breast cancer cell growth may diverge depending on ERα expression, when in ERα-negative cells it exerts anti-proliferative properties while in ERα-positive ones it promotes cancer cell proliferation [180]. Here, ADIPOQ is linked to breast carcinoma.